Envista Holdings Corp. (NVST)
26.94
-0.09
(-0.33%)
USD |
NYSE |
Apr 16, 16:00
27.17
+0.23
(+0.85%)
Pre-Market: 09:08
Envista Holdings Research and Development Expense (Quarterly) : 32.10M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Globus Medical, Inc. | 36.16M |
| Boston Scientific Corp. | 569.00M |
| Intuitive Surgical, Inc. | 352.90M |
| Dentsply Sirona, Inc. | 40.00M |
| Solventum Corp. | 168.00M |